Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Hanmi Out-licenses pan-RAF Inhibitor to Genentech for $920 Million
  Fosun Forms $100 Million China Medical Device JV with Intuitive Surgical
  Zai Lab Acquires China Rights to TESARO's PARP Inhibitor
  ReedCoor Raises $23 Million from China Investors for Novel NGS Technology
  Huanzhong Biotech to Market Concepta's Fertility Product in China
  Huapont In-Licenses China Rights to Histogen's Stem Cell Hair Growth Injections
  China BioPharma Capital Invests in Quantapore, a Sequencing Device Maker
  China's CANbridge Starts Taiwan Trial of Novel Brain Cancer Drug
  Neusoft and Infinity Announce a $250 Million China-Israel Investment Fund
  MicuRx Raises $55 Million for China-US Development of Novel Antibiotic
 
Login

  

    
   
ChinaBio® Events